A solution to sparse evidence, heterogeneous studies, and disconnected networksRead the whitepaper
Innovative early clinical solutions that will advance your drug development strategy.
Expertise in mission-critical pricing, market access, and reimbursement.
Transforming recruitment through patient-centric trials and real-world, real-time data.
ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.
ICON is the world's largest provider of FSP services.